Sano offers a disposable, low cost, Point-of-Care (POC) diagnostic platform with first focus on chronic wounds, quantitatively measuring wound biochemistry (enzymes called MMPs) to personalize treatment, promote faster healing, and reduce treatment costs. In parallel, Sano will trial and commercialize an early equine arthritis diagnostic for earlier revenue in Q4 2014. Six other human and vet diseases that are characterized by elevated MMPs will be evaluated sequentially thereafter.

2014 Boston Gold Winner
Sub industry